A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis

NCT ID: NCT06049017

Last Updated: 2025-11-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

PHASE2

Total Enrollment

252 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-10-09

Study Completion Date

2026-01-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the safety and effectiveness of JNJ-77242113 compared with placebo in participants with moderately to severely active ulcerative colitis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colitis, Ulcerative

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1: JNJ-77242113 Dose-1

Participants will receive JNJ-77242113 Dose-1 tablets orally from Week 0 through Week 28. Participants who complete the Week 28 assessments and have achieved clinical response at Week 28 and who, in the opinion of the investigator, will continue to benefit from treatment with study intervention will continue in the 48-week long term extension (LTE) period and receive the same treatment up to Week 76.

Group Type EXPERIMENTAL

JNJ-77242113

Intervention Type DRUG

JNJ-77242113 tablet will be administered orally.

Group 2: JNJ-77242113 Dose-2

Participants will receive JNJ-77242113 Dose-2 tablets orally from Week 0 through Week 28. Participants who complete the Week 28 assessments and have achieved clinical response at Week 28 and who, in the opinion of the investigator, will continue to benefit from treatment with study intervention will continue in the 48-week LTE period and receive the same treatment up to Week 76.

Group Type EXPERIMENTAL

JNJ-77242113

Intervention Type DRUG

JNJ-77242113 tablet will be administered orally.

Group 3: JNJ-77242113 Dose-3

Participants will receive JNJ-77242113 Dose-3 tablets orally from Week 0 through Week 28. Participants who complete the Week 28 assessments and have achieved clinical response at Week 28 and who, in the opinion of the investigator, will continue to benefit from treatment with study intervention will continue in the 48-week LTE period and receive the same treatment up to Week 76.

Group Type EXPERIMENTAL

JNJ-77242113

Intervention Type DRUG

JNJ-77242113 tablet will be administered orally.

Group 4: Placebo

Participants will receive placebo tablets orally from Week 0 through Week 28. Placebo-treated participants who meet the criteria of inadequate response at Week 16, will receive JNJ-77242113 Dose-3 tablet orally through Week 28. Participants who complete the Week 28 assessments and have achieved clinical response at Week 28 and who, in the opinion of the investigator, will continue to benefit from treatment with study intervention, will continue in the 48-week LTE period and receive the same treatment up to Week 76.

Group Type EXPERIMENTAL

JNJ-77242113

Intervention Type DRUG

JNJ-77242113 tablet will be administered orally.

Placebo

Intervention Type DRUG

Placebo tablet will be administered orally.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

JNJ-77242113

JNJ-77242113 tablet will be administered orally.

Intervention Type DRUG

Placebo

Placebo tablet will be administered orally.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Signed informed consent form 18 years of age or older
* Documented diagnosis of ulcerative colitis (UC) of at least 12 weeks prior to screening
* Moderately to severely active UC as per the modified Mayo score
* Demonstrated inadequate response to or intolerance of conventional therapy and/or advanced therapy as defined in the protocol

Exclusion Criteria

* Participants with current or prior diagnosis of fulminant colitis and/or toxic megacolon
* UC limited to rectum only or to less than (\<) 15 centimeters (cm) of colon
* Presence of a stoma
* Presence or history of fistula
* History of extensive colonic resection (example, \<30 cm of colon remaining)
* Diagnosis of indeterminate colitis, microscopic colitis, ischemic colitis, Crohn's colitis or clinical findings suggestive of Crohn's disease
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Janssen Research & Development, LLC

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Janssen Research & Development, LLC Clinical Trial

Role: STUDY_DIRECTOR

Janssen Research & Development, LLC

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinnova Research

Anaheim, California, United States

Site Status

Hoag Memorial Hospital

Newport Beach, California, United States

Site Status

Medical Associates Research Group, Inc.

San Diego, California, United States

Site Status

Peak Gastroenterology Associates

Colorado Springs, Colorado, United States

Site Status

I.H.S. Health. LLC

Kissimmee, Florida, United States

Site Status

Endoscopic Research Inc

Orlando, Florida, United States

Site Status

GCP Clinical Research

Tampa, Florida, United States

Site Status

Atlanta Gastroenterology Associates

Atlanta, Georgia, United States

Site Status

Gastroenterology of Southern Indiana

New Albany, Indiana, United States

Site Status

Cotton O'Neil Digestive Health Center

Topeka, Kansas, United States

Site Status

Ochsner Medical Center

Jefferson, Louisiana, United States

Site Status

Tandem Clinical Research

Marrero, Louisiana, United States

Site Status

Mercy Medical Center

Baltimore, Maryland, United States

Site Status

Mayo Clinic Rochester

Rochester, Minnesota, United States

Site Status

New York Gastroenterology Associates

New York, New York, United States

Site Status

DiGiovanna Institute for Medical Education & Research

North Massapequa, New York, United States

Site Status

University North Carolina at Chapel Hill

Chapel Hill, North Carolina, United States

Site Status

Atrium Health

Charlotte, North Carolina, United States

Site Status

Charlotte Gastroenterology and Hepatology, PLLC

Charlotte, North Carolina, United States

Site Status

Northshore Gastroenterology Research, LLC

Westlake, Ohio, United States

Site Status

Digestive Disease Specialists Inc

Oklahoma City, Oklahoma, United States

Site Status

Gastroenterology Associates P.A.

Greenville, South Carolina, United States

Site Status

DHAT Research Institute

Garland, Texas, United States

Site Status

Amel Med LLC Research

Georgetown, Texas, United States

Site Status

Accurate Clinical Research, Inc.

Humble, Texas, United States

Site Status

Caprock Gastro Research

Lubbock, Texas, United States

Site Status

Southern Star Research Institute, LLC

San Antonio, Texas, United States

Site Status

Tyler Research Institute, LLC

Tyler, Texas, United States

Site Status

Care Access Research, Ogden

Ogden, Utah, United States

Site Status

Gastroenterology Associates of Tidewater

Chesapeake, Virginia, United States

Site Status

Washington Gastroenterology, PLLC

Bellevue, Washington, United States

Site Status

Washington Gastroenterology, PLLC

Tacoma, Washington, United States

Site Status

Cer Instituto Medico

Buenos Aires, , Argentina

Site Status

CIPREC

Buenos Aires, , Argentina

Site Status

Gedyt - Consultorios Gastroenterologia

Buenos Aires, , Argentina

Site Status

Hospital Provincial del Centenario

Rosario, , Argentina

Site Status

Sanatorio 9 de Julio

San Miguel de Tucumán, , Argentina

Site Status

Sunshine Coast University Hospital

Birtinya, , Australia

Site Status

Blacktown Hospital

Blacktown, , Australia

Site Status

Concord Repatriation General Hospital

Concord, , Australia

Site Status

Wollongong Private Hospital

Wollongong, , Australia

Site Status

CHU Saint-Pierre

Brussels, , Belgium

Site Status

AZ Sint-Lucas

Ghent, , Belgium

Site Status

Ghent University Hospital

Ghent, , Belgium

Site Status

Universitair Ziekenhuis Leuven

Leuven, , Belgium

Site Status

Centre Hospitalier Universitaire de Liege Domaine Universitaire du Sart Tilman

Liège, , Belgium

Site Status

Vitaz

Sint-Niklaas, , Belgium

Site Status

UNESP - Faculdade de Medicina da Universidade Estadual Paulista - Campus Botucatu

Botucatu, , Brazil

Site Status

L2IP Instituto de Pesquisas Clinicas

Brasília, , Brazil

Site Status

CDC - Centro Digestivo de Curitiba

Curitiba, , Brazil

Site Status

Hospital de Clinicas de Porto Alegre - Hospital de Clinicas

Porto Alegre, , Brazil

Site Status

Pesquisare Saude

Santo André, , Brazil

Site Status

BR TRIALS Ensaios Clinicos e Consultoria Ltda

São Paulo, , Brazil

Site Status

Instituto D Or de Pesquisa e Ensino

São Paulo, , Brazil

Site Status

INTEGRAL Pesquisa e Ensino

Votuporanga, , Brazil

Site Status

Gastroenterology and Internal Medicine Research Institute (GIRI)

Edmonton, Alberta, Canada

Site Status

Barrie GI Associates

Barrie, Ontario, Canada

Site Status

London Health Sciences Centre

London, Ontario, Canada

Site Status

ABP Research Services Corp.

Oakville, Ontario, Canada

Site Status

Centre Hospitalier de l'Universite de Montreal

Montreal, Quebec, Canada

Site Status

The second Xiangya Hospital of Central South University

Changsha, , China

Site Status

Chongqing General Hospital

Chongqing, , China

Site Status

The First Affiliated Hospital Sun Yat sen University

Guangzhou, , China

Site Status

The Sixth Affiliated Hospital Sun Yat sen University

Guangzhou, , China

Site Status

Sir Run Run Shaw Hospital Zhejiang University School of Medicine

Hangzhou, , China

Site Status

Qilu Hospital of Shandong University

Jinan, , China

Site Status

Lanzhou University Second Hospital

Lanzhou, , China

Site Status

Nanjing Drum Tower Hospital

Nanjing, , China

Site Status

Shengjing Hospital Of China Medical University

Shenyang, , China

Site Status

Union Hospital Tongji Medical College of Huazhong University of Science and Technology

Wuhan, , China

Site Status

Wuxi People s Hospital

Wuxi, , China

Site Status

The Second Affiliated Hospital of Air Force Medical University - Tangdu Hospital

Xi'an, , China

Site Status

Nemocnice Ceske Budejovice

České Budějovice, , Czechia

Site Status

Gastroenterologie, s.r.o., Hradec Kralove

Hradec Kralova, , Czechia

Site Status

Hepato-gastroenterologie HK, s.r.o.

Hradec Králové, , Czechia

Site Status

ISCARE a.s.

Prague, , Czechia

Site Status

Nemocnice Slany

Slaný, , Czechia

Site Status

CHRU Besancon Hopital Jean Minjoz

Besançon, , France

Site Status

APHP - Hopital Henri Mondor

Créteil, , France

Site Status

CHRU de Lille Hopital Claude Huriez

Lille, , France

Site Status

Clinique Ambroise Pare

Neuilly-sur-Seine, , France

Site Status

CHU de Nice Hopital de l Archet

Nice, , France

Site Status

CHU Nimes Hopital Caremeau

Nîmes, , France

Site Status

APHP - Hopital Bichat - Claude Bernard

Paris, , France

Site Status

Hospices Civils de Lyon CHU Lyon Sud

Pierre-Bénite, , France

Site Status

CHU Saint Etienne Hopital Nord

Saint-Priest-en-Jarez, , France

Site Status

CHU Toulouse - Hopital de Rangueil

Toulouse, , France

Site Status

CHU de Nancy_ Hopital Brabois

Vandœuvre-lès-Nancy, , France

Site Status

Klinikum Augsburg

Augsburg, , Germany

Site Status

Krankenhaus Waldfriede Mitte

Berlin, , Germany

Site Status

Universitaetsklinikum Carl Gustav Carus TU Dresden

Dresden, , Germany

Site Status

Medizinische Hochschule Hannover

Hanover, , Germany

Site Status

Universitatsklinikum Schleswig Holstein Kiel

Kiel, , Germany

Site Status

Eugastro GmbH

Leipzig, , Germany

Site Status

Staedtisches Klinikum Lueneburg

Lüneburg, , Germany

Site Status

Gastroenterologische Gemeinschaftspraxis Minden

Minden, , Germany

Site Status

Semmelweis Egyetem

Budapest, , Hungary

Site Status

Semmelweis Egyetem

Budapest, , Hungary

Site Status

Pannónia Magánorvosi Centrum Kft

Budapest, , Hungary

Site Status

Vasutegeszsegugyi Nonprofit Kozhasznu Kft

Debrecen, , Hungary

Site Status

Debreceni Egyetem Gasztroenterologiai Klinika

Debrecen, , Hungary

Site Status

Clinexpert Kft

Gyöngyös, , Hungary

Site Status

S. R. Kalla Memorial General Hospital

Jaipur, , India

Site Status

Midas Hospital

Nagpur, , India

Site Status

Govind Ballabh Pant Hospital

New Delhi, , India

Site Status

SIDS Hospital & Research Centre

Surat, , India

Site Status

Fondazione IRCCS Ca Granda Ospedale Policlinico Di Milano

Milan, , Italy

Site Status

Ospedale San Raffaele di Milano

Milan, , Italy

Site Status

Ospedale Sacro Cuore Don Calabria

Negrar, , Italy

Site Status

Azienda Ospedaliera San Camillo - Roma

Roma, , Italy

Site Status

Fondazione Policlinico Universitario A Gemelli IRCCS

Roma, , Italy

Site Status

Istituto Clinico Humanitas

Rozzano, , Italy

Site Status

Casa Sollievo Della Sofferenza IRCCS

San Giovanni Rotondo, , Italy

Site Status

Sai Gastroenterology Proctology

Fujiidera-shi, , Japan

Site Status

Hamamatsu University Hospital

Hamamatsu, , Japan

Site Status

Kagoshima IBD Gastroenterology Clinic

Kagoshima, , Japan

Site Status

Tsujinaka Hospital Kashiwanoha

Kashiwa, , Japan

Site Status

Aoyama Naika Clinic

Kobe, , Japan

Site Status

Kinshukai Infusion Clinic

Osaka, , Japan

Site Status

Japanese Red Cross Osaka Hospital

Osaka, , Japan

Site Status

Toho University Sakura Medical Center

Sakura, , Japan

Site Status

Sapporo Tokushukai Hospital

Sapporo, , Japan

Site Status

Sapporo Higashi Tokushukai Hospital

Sapporo, , Japan

Site Status

National Hospital Organization Shizuoka Medical Center

Shimizu, , Japan

Site Status

Tokyo Metropolitan Bokutoh Hospital

Sumida Ku, , Japan

Site Status

Mie University Hospital

Tsu, , Japan

Site Status

Yokohama City University Medical Center

Yokohama, , Japan

Site Status

Hospital Sultanah Aminah

Johor Bahru, , Malaysia

Site Status

Sultan Idris Shah Hospital

Kajang, , Malaysia

Site Status

University Malaya Medical Centre

Kuala Lumpur, , Malaysia

Site Status

Centrum Medyczne Medis ManerMed Sp Z O O

Bydgoszcz, , Poland

Site Status

Centrum Medyczne Lukamed Spolka z Ograniczona Odpowiedzialnoscia

Chojnice, , Poland

Site Status

Centrum Medyczne Plejady

Krakow, , Poland

Site Status

Centrum Medyczne Medyk

Rzeszów, , Poland

Site Status

Sonomed Sp. z o.o.

Szczecin, , Poland

Site Status

GASTROMED Sp. z o.o.

Torun, , Poland

Site Status

Centralny Szpital Kliniczny Mswia

Warsaw, , Poland

Site Status

Bodyclinic Sp. z o.o. sp. k

Warsaw, , Poland

Site Status

Medical Network Spolka z o.o. WIP Warsaw IBD Point Profesor Kierkus

Warsaw, , Poland

Site Status

Centrum Medyczne Oporow

Wroclaw, , Poland

Site Status

Melita Medical Sp. z o.o.

Wroclaw, , Poland

Site Status

EMC Instytut Medyczny SA

Wroclaw, , Poland

Site Status

Spital Memorial

Bucharest, , Romania

Site Status

S C Delta Health Care S R L

Bucharest, , Romania

Site Status

Digenio - Centrul Medical de Gastroenterologie, Hepatologie si Endoscopie Digestiva

Cluj-Napoca, , Romania

Site Status

Centrul Medical Valahia

Ploieşti, , Romania

Site Status

Inje University Haeundae Paik Hospital

Busan, , South Korea

Site Status

Yeungnam University Hospital

Daegu, , South Korea

Site Status

Seoul National University Hospital

Seoul, , South Korea

Site Status

Kangbuk Samsung Hospital

Seoul, , South Korea

Site Status

Asan Medical Center

Seoul, , South Korea

Site Status

Samsung Medical Center

Seoul, , South Korea

Site Status

The Catholic university of Korea, St. Vincent's Hospital

Suwon, , South Korea

Site Status

Hosp. Univ. Fundacion Alcorcon

Alcorcón, , Spain

Site Status

Hosp. Arquitecto Marcide

Ferrol, , Spain

Site Status

Hosp. de Cabuenes

Gijón, , Spain

Site Status

Hosp. Univ. La Paz

Madrid, , Spain

Site Status

Hosp. Univ. Pta. de Hierro Majadahonda

Majadahonda, , Spain

Site Status

Hosp. Clinico Univ. de Santiago

Santiago de Compostela, , Spain

Site Status

Hosp. Virgen Macarena

Seville, , Spain

Site Status

Hosp. Ntra. Sra. de Valme

Seville, , Spain

Site Status

Hosp. Clinico Univ. de Valencia

Valencia, , Spain

Site Status

Hosp. Univ. I Politecni La Fe

Valencia, , Spain

Site Status

Hosp. Alvaro Cunqueiro

Vigo, , Spain

Site Status

Gazi University Medical Faculty

Ankara, , Turkey (Türkiye)

Site Status

Uludag Universitesi Tıp Fakultesi Hastanesi

Bursa, , Turkey (Türkiye)

Site Status

Ege Universitesi Tip Fakultesi

Izmir, , Turkey (Türkiye)

Site Status

Mersin University Medical Faculty

Mersin, , Turkey (Türkiye)

Site Status

Fairfield General Hospital

Bury, , United Kingdom

Site Status

Addenbrookes Hospital

Cambridge, , United Kingdom

Site Status

Barts Health NHS Trust

London, , United Kingdom

Site Status

Guys St Thomas Hospital

London, , United Kingdom

Site Status

Kings College Hospital

London, , United Kingdom

Site Status

St Georges University Hospital NHS Foundation Trust

London, , United Kingdom

Site Status

Oxford University Hospitals NHS Foundation Trust

Oxford, , United Kingdom

Site Status

Whiston Hospital

Prescot, , United Kingdom

Site Status

Southampton University Hospital

Southampton, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Australia Belgium Brazil Canada China Czechia France Germany Hungary India Italy Japan Malaysia Poland Romania South Korea Spain Turkey (Türkiye) United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

77242113UCO2001

Identifier Type: OTHER

Identifier Source: secondary_id

2023-504673-20-00

Identifier Type: REGISTRY

Identifier Source: secondary_id

77242113UCO2001

Identifier Type: -

Identifier Source: org_study_id